Sichuan Goldstone Asia Pharmaceutical Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 362.79 million compared to CNY 419.79 million a year ago. Net income was CNY 89.82 million compared to CNY 143.46 million a year ago.

Basic earnings per share from continuing operations was CNY 0.2236 compared to CNY 0.3571 a year ago. Diluted earnings per share from continuing operations was CNY 0.2236 compared to CNY 0.3571 a year ago.